Get complete coverage of ACR Convergence 2022 here. Plus, explore our Gout, Axial Spondyloarthritis and Psoriatic Arthritis Resource Centers for research reviews, case reports and clinical articles on advances in the diagnosis and management of these conditions.
Focused Content
Gout Resource Center
Explore our coverage of the top research and additional gout information presented at ACR Convergence 2021 and much more.
[View]Axial Spondyloarthritis Resource Center
Explore our coverage of the top research in axial spondyloarthritis, additional information
[View]
presented at ACR Convergence 2022 and much more.Psoriatic Arthritis in Focus
Explore our coverage of the top research in psoriatic arthritis and additional information presented at ACR Convergence 2022 and much more.
[View]
Previous ACR Meetings
- ACR Convergence 2021
- ACR Convergence 2020
- 2019 ACR/ARP Annual Meeting
- 2018 ACR/ARHP Annual Meeting
- 2017 ACR/ARHP Annual Meeting
- 2016 ACR/ARHP Annual Meeting
- 2015 ACR/ARHP Annual Meeting
- 2014 ACR/ARHP Annual Meeting
- 2011 ACR/ARHP Annual Meeting
- 2010 ACR/ARHP Annual Scientific Meeting
- 2006 ACR Annual Meeting
- ACR/ARHP Annual Meeting
- Annual Meeting
Complete Coverage

Rheumatology Online: Disseminating the State of the Art on Social Media at ACR Convergence 2022
PHILADELPHIA—A session on social media in rheumatology at ACR Convergence 2022 focused on how to use social media to promote one’s work and collaborate on international research projects, as well as the use of podcasts in educating rheumatologists. Engaging with Social Media at Conferences Jean Liew, MD, MS, assistant professor of medicine in the Section… [Read More]

A World of Difference: Updates from the Global Rheumatology Summit
The second annual Global Rheumatology Summit focused on climate change, conflict and migration, as well as other global issues in rheumatology.... [Read More]

Overcoming Healthcare Disparity
PHILADELPHIA—Quality improvement (QI) tools in pediatric rheumatology can help overcome health outcome disparities that are based on race, gender identity, income and other factors, experts said in a session at ACR Convergence. With it well established that these disparities exist, it’s time to begin eliminating them, said Emily Smitherman, MD, MS, assistant professor of pediatric… [Read More]
FDA Officials Speak Out: New Approvals & Safety Concerns Discussed
PHILADELPHIA—Officials from the U.S. Food & Drug Administration discussed recent drug approvals and drug safety issues at ACR Convergence in November in a session that captured the flurry of activity in the rheumatology sphere at the agency over the past year. Sabiha Khan, MD, clinical reviewer in the Division of Rheumatology and Transplant Medicine at… [Read More]
Mitigating Drug Shortages: FDA Officials Say Communication Is Crucial
PHILADELPHIA—The most vital component of avoiding drug shortages is early communication, officials from the U.S. Food & Drug Administration (FDA) said in a session at ACR Convergence 2022 in November. “Early notification is key in order to prevent and mitigate shortages,” said Hyun Son, PharmD, a member of the Drug Shortage Staff with the FDA… [Read More]
Advocacy Is Central to Patient Care, Distinguished Lecturer Says
When she saw vaping taking hold at a middle school, Kamala Nola, PharmD, MS, spoke up about concerns for the students’ risk of rheumatic disease and other health issues. At ACR Convergence 2022, Dr. Nola emphasized that every healthcare professional can act as an advocate through everyday actions.... [Read More]

Insights into Methotrexate Toxicity in Elderly Patients with Rheumatic Disease
Data from a small study show that severe methotrexate toxicity in patients who are 70 years of age and older and have rheumatic disease may be associated with poor renal function and the use of diuretic treatments.... [Read More]

Are You Listening? Young Patient Advocates Call for Change
PHILADELPHIA—Representatives of the Young Patients’ Autoimmune Research and Empowerment Alliance (YP AREA) led a panel titled Young Patients with Big Ideas Will Revolutionize Healthcare and Research, in which they discussed their work as advocates for adolescent and young adult (AYA) patients. YP AREA’s mission is to make autoimmune research more accessible and inclusive by involving… [Read More]
COVID-19 Vaccine Responses Among the Immunosuppressed
PHILADELPHIA—Patients with rheumatic diseases often mount an adequate immune response after receiving COVID-19 vaccinations, but that is not always the case, and certain medications make patients more prone to having an insufficient response, said Judith James, MD, PhD, chair, Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, at an ACR Convergence… [Read More]

Contraception, Abortion & Rheumatic Disease after Dobbs
PHILADELPHIA—As rheumatologists, we care for patients who may or may not want to become pregnant. We aren’t obstetricians or gynecologists, but several of the drugs we prescribe for active rheumatic disease can negatively affect pregnancy outcomes. It’s imperative we understand how to effectively counsel our patients with rheumatic disease on the risks and benefits of… [Read More]
- 1
- 2
- 3
- …
- 5
- Next Page »